NEVEZYNE
Created in 2023
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
183Activities
Technologies
Entity types
Location
2 Rue Félix le Dantec, 22440 Ploufragan, France
Ploufragan
France
Employees
Scale: 2-10
Estimated: 3
Engaged corporates
4
1 1Added in Motherbase
3 weeks, 3 days ago
healthtech Value proposition
[Automatic translation follows] Nevezyne develops its own protein expression systems and offers its expertise in the expression of recombinant proteins, for research programs, for diagnosis in animal and human health
Protein expression, Baculovirus system, Protein purification, and Bacterial systemOriginal language
Nevezyne développe ses propres systèmes d'expression de protéines et propose son expertise dans l’expression de protéines recombinantes, pour des programmes de recherches, pour le diagnostic en santé animale, humaine
Expression de protéines, Système baculovirus, Purification de protéines, and Système bactérien
Services d'expression de protéines recombinantes thérapeutiques basée en France
spécialisés dans l'expression, de protéines recombinantes thérapeutiques, dans les systèmes BEVS (cellules insectes). Nous proposons, également, nos services dans l'expression et la purification de vos protéines d'intérêts
https://nevezyne.fr/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 INNOZH Civic and Social Organizations | INNOZH Civic and Social Organizations | Other 23 Oct 2023 | | |
 La French Tech Rennes St Malo Public business cluster, French Tech, Software Development | La French Tech Rennes St Malo Public business cluster, French Tech, Software Development | Other 30 Jun 2024 | | |
 Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 12 Feb 2024 | | |
 SATT Ouest Valorisation Research, Startup accelerator & VC, Research Services | SATT Ouest Valorisation Research, Startup accelerator & VC, Research Services | Other 25 Mar 2024 | | |